The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target—a narrative review

BACKGROUND AND OBJECTIVE: The genetic nature of cancer provides the rationale to support the need for molecular diagnosis and patient selection for individualised antineoplastic treatments that are the best in both tolerability and efficacy for each cancer patient, including non-small cell lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnuolo, Alessia, Maione, Paolo, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271439/
https://www.ncbi.nlm.nih.gov/pubmed/35832439
http://dx.doi.org/10.21037/tlcr-21-948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271439/
https://www.ncbi.nlm.nih.gov/pubmed/35832439
http://dx.doi.org/10.21037/tlcr-21-948

Ejemplares similares